InvestorsHub Logo
Followers 20
Posts 936
Boards Moderated 0
Alias Born 04/02/2015

Re: pgsd post# 578146

Monday, 03/20/2023 8:51:58 AM

Monday, March 20, 2023 8:51:58 AM

Post# of 708376
For NovoCure Ltd (NASDAQ:NVCR), JP Morgan downgraded the previous rating of Neutral to Underweight. NovoCure earned $0.36 in the fourth quarter, compared to $0.25 in the year-ago quarter. At the moment, the stock has a 52-week-high of $120.03 and a 52-week-low of $56.39. NovoCure closed at $64.43 at the end of the last trading period.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News